Stability over time of hematological variables in 197 children with sickle cell anemia by Odenheimer, Daniel J. et al.
American Journal of Medical Genetics 18: 461-470 (1984) 
Stability Over Time of Hematological 
Variables in 197 Children With Sickle 
Cell Anemia 
Daniel J. Odenheimer, Charles F. Whitten, Donald A. Rucknagel, Sharada A. 
Sarnaik, and Charles F. Sing 
Department of Human Genetics, University of Michigan Ann Arbor (0. J.O., D.A. R., 
C. F. S.), and Comprehensive Sickle Cell Center and Department of Pediatrics, 
Wayne State University, Detroit (C. F. W., S. A. S.) 
One hundred ninety-seven children with sickle cell anemia were followed for 4 
years at the Wayne State Comprehensive Sickle Cell Center to evaluate the 
stability of the hematological variables (Hb, Hct, RBC count, MCV, %HbF and 
%HBA2) over time. The mean values of the hematological measurements taken 
during three separate 16-month intervals were used to represent an individual’s 
values. The correlations of the hematological variables between intervals ranged 
from a low of 0.46 for %HBA2 to a high of 0.91 for %HbF. Correlations that 
spanned two intervals (an average of 32 months) were of the same magnitude as 
those that spanned only one interval (an average of 16 months), suggesting that 
there was no decrease in the degree of stability of these variables as the time 
between measurements increased. The stability of the correlations between varia- 
bles within intervals, and the stability of the coefficients of the first two principal 
components of the six hematological variables over time suggested that the rela- 
tionships among variables were also stable. 
In a recent report [Odenheimer et al, 19831, we used the values of the six 
hematological variables collected at an individual’s first visit to the sickle cell 
center to identify four hematologically distinct subgroups of children. In the 
current report, we found that as many as 83% of the individuals remained in the 
same subgroup in at least two of the three follow-up intervals, suggesting that the 
factors that contributed to this classification were the result of stable, rather than 
transient phenomena. 
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INTRODUCTION 
The clinical variability of patients with sickle cell anemia is well known; 
likewise it is well known that the severity of a patient’s condition may flucuate with 
time. Recently, Odenheimer et a1 [ 19831 reported the use of a profile of hematological 
data (Hb, Hct, RBC count, MCV, %HbF and %HBA2) to identify heterogeneity in 
children with sickle cell anemia. Subgroups differed significantly for a number of 
measures of disease severity, including the proportion that ever had pneumonia, 
dactylitis, a transfusion, and a hospitalization before enrolling in the Wayne State 
University Comprehensive Center for Sickle Cell Anemia. The hematological data 
used in identifying these subgroups were collected at a patient’s initial visit to the 
center. The objective of the current study was to determine whether the age-adjusted 
hematological variables and the linear relationships among these variables were stable 
over time. Specifically, our analyses were designed to answer the following: 1) Do 
individuals maintain their relative rank in the sample over time for each of the 
hematological variables considered? 2) Are the relationships among variables stable 
over time? and 3) On follow-up, do individuals tend to remain in the same subgroup 
to which they were assigned at initial assessment. 
If the hematological variables are stable over time, cross-sectional data may be 
useful for the prediction of subsequent hematological status and the associated clinical 
symptoms in children with sickle cell anemia. In addition, the stability of the subgroups 
identified at initial assessment establishes these subgroups as candidates for analyses 
to identify the genetic and environmental factors that explain the heterogeneity of 
sickle cell anemia. 
MATERIALS AND METHODS 
Sample 
A description of the large sample of patients seen at initial assessment at the 
Wayne State Comprehensive Sickle Cell Center has been presented elsewhere [Oden- 
heimer et al, 19831. The sample consists of 360 children (age 1-18 years) with sickle 
cell anemia who were first seen at the center between October 1973 and October 
1980. Of the 360 patients seen at initial assessment, 225 were included in the cluster 
analysis [Odenheimer et al, 19831; the remaining 135 patients were excluded because 
of incomplete data. The sample studied here consists of 197 patients (136 involved in 
the cluster analysis sample and 61 others) who were followed for at least 4 years. 
These 197 individuals were not significantly different from the 163 patients who were 
not followed with respect to the characteristics: proportion of males or females, 
average age, or the mean values of Hb, Hct, RBC count, %HbF, %HBA2, and MCV 
measured at their initial assessment visit. The main reasons for not being followed 
include 1) the patient did not enter the study early enough to have been followed for 
4 years, 2) the patient reached his or her 18th birthday before being followed for 4 
years and was transferred to the adult clinic, 3) a patient’s family moved out of the 
Detroit area, 4) a patient began seeing a private physician, 5 )  a patient died before 4 
years of follow-up were completed, and 6) a patient’s hematological profile was 
measured only once in the 4-year follow-up period. In addition, we excluded 35 
patients who were on a special transfusion program for individuals who had experi- 
enced a previous stroke. 
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Study Design 
The follow-up period was divided into three 16-month intervals that began at a 
patient’s initial assessment visit. A 16-month interval was chosen because it maxi- 
mized the number of patients whose hematological status was measured at least once 
per interval. The number of times a blood sample was assayed during the follow-up 
varied markedly among individuals. For example, the number of blood samples taken 
during the first interval ranged from one to 13 (mean 4.9). However, in no case was 
an individual’s mean value for a variable within an interval significantly correlated 
with the number of measurements taken. Furthermore, there was no significant 
difference in the mean number of follow-up measurements when comparing those 
with and without pain crises, hospitalizations, pneumonia, or dactylitis before enroll- 
ing at the center. However, there was a significant increase (P < 0.05) in the number 
of measurements taken on individuals who had had at least one transfusion (mean 
5.2) as compared to those who had never been transfused (mean 4.5). For all 
subsequent analyses, we used the means of the hematological measurements taken 
during an interval to represent an individual’s values. 
The hematologic values were obtained using the Coulter Counter, model S.  
HBA2 was measured either by elution from cellulose acetate electrophoresis strips 
[Schneider, 19741 or radial immunodiffusion assay [Chudwin and Rucknagel, 19741. 
Initially HbF was measured by alkali denaturation [Singer et al, 19.511, but subse- 
quently by radial immunodiffusion assay of whole blood [Chudwin and Rucknagel, 
19741. The two sets of values were merged separately for each sex by adding the 
overall HbF mean to the residuals from the linear regression of each method on age 
[Neter and Wasserman, 19741. 
Statistical Analysis 
We used the linear regression of an individual’s mean value on his average age 
for the interval to remove the age variation in these data. The bivariate relationships 
between the mean values of the age-adjusted hematological variables within a follow- 
up interval were evaluated using the Pearson product-moment correlation. The rela- 
tionship between an individual’s mean values for a variable at two different intervals 
was evaluated using the Pearson product-moment correlation and Spearman’s rank 
correlation. The results using these two methods were very similar; thus, results of 
only the Pearson product-moment correlations will be reported here. 
The primary linear relationships among the six hematological variables were 
evaluated in each follow-up period using the first two principal components of the 
correlation matrix [Morrison, 19761. The consistency of the coefficients of the 
principal components are a measure of the stability of the multivariate relationships 
among the hematological variables. The first principal component accounts for the 
greatest percentage of variability represented by this set of variables, and the other 
five principal components each explain a progressively smaller percentage of the 
variability. Each principal component is uncorrelated with all other principal 
components. 
Linear discriminant analysis was used to determine whether the 136 individuals 
included in both the cluster analysis at initial assessment and the sample studied here 
tended to remain in the same subgroup on follow-up as they were assigned to at initial 
assessment. Discriminant scores were calculated for each individual at the three 
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"Individuals in the ( I ,  2), ( I ,  3), and (2. 3) categories had blood assayed in only two of three intervals 
"Test of niean difference between intervals. 
'Mean i SD. 
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follow-up periods using the initial assessment classification as the stratum for the 
analysis and the six hematological variables measured on follow-up as the independent 
variables to estimate the coefficients of the discriminant functions. Using these 
functions, and a priori probabilities that were equal for each stratum, we calculated 
the probability that an individual was classified into groups 1, 2, 3 ,  and 4 on follow- 
up and assigned an individual to the group for which this probability was the greatest. 
An individual’s classification on follow-up was then compared with that established 
by the cluster analysis at initial assessment. 
RESULTS 
The hematological data were age-adjusted separately by sex. The percent vari- 
ability explained by age was approximately 5% for Hb, Hct, RBC count, and MCV; 
7.5% for %HBA,; and 23% for %HbF. The age-adjusted hematological data at each 
interval are presented in Table I. With the exception of %HBA2, the means do not 
change significantly over time. Although mean %HBA2 values are significantly 
higher at intervals 2 and 3 than at interval 1, the size of the difference is small. For 
all subsequent analyses, the data on the few individuals whose hematological status 
was evaluated in only two of three intervals were pooled with the data on the 
individuals evaluated in all three intervals. 
The correlations of the hematological variables between intervals are presented 
in Table 11. They range from a low of 0.46 for %HBA2 in males (interval 2 and 
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interval 3), to a high of 0.91 for %HbF in females (interval 1 and interval 2). All 
correlations are significantly different from zero at the 0.0001 level of probability. In 
almost all instances, the correlations are stronger in females than in males. For Hb, 
Hct, and RBC count, these differences between sexes are statistically significant (P 
~ 0 . 0 5 ) .  The correlations that span two intervals (ie, interval 1 with interval 3) are of 
the same magnitude as those that span only one interval (ie, interval 1 with interval 
2,  and interval 2 with interval 3 ) .  
The correlations between variables within each interval are presented in Table 
111. In general, the correlations are similar in the three intervals. For example, the 
correlation between Hb and %HbF in males is 0.40 in interval I ,  0.48 in interval 2, 
and 0.49 in interval 3. In the sample of males, the correlation matrices of the six 
hematological variables in the three intervals are not significantly different from one 
another (P>0.40). In the female sample, the correlations are also generally stable. 
However, in a few instances there are differences in the magnitude of the correlations. 
For example, the correlations between Hb and %HbF are similar at interval 1 (r = 
0.47) and interval 2 (r = O.Sl ) ,  but lower at interval 3 (r = 0.25). Although these 
correlations between Hb and %HbF are not significantly different from one another 
(P > 0. lo), there is evidence that the correlations matrices in the female sample are 
not homogenous (P = 0.06). This difference is primarily attributable to the different 
correlation structure at interval 3 from that at intervals 1 and 2. 
The primary linear relationships among the hematological variables are identi- 
fied by the first two principal components presented in Table IV. These principal 
components account for approximately 50% and 30% respectively, of the total 
variability represented by all six hematological variables at each interval considered. 
In general, the coefficients of the principal components are stable across intervals, 
suggesting that the multivariate relationships among variables are approximately the 
same in each of the three follow-up intervals. 







Females - Interval 
1 0.94 ( 94)" 0.79 ( 94) 0.01 (94) 0.47 (89) -0.23 (88) 
2 0.94 ( 92) 0.81 ( 92) -0.26 (92) 0.51 (83) -0.22 (77) 
3 0.96 ( 95) 0.78 ( 95) -0.22 (95) 0.25 (78) -0.06 (69) 
1 0.91 ( 98) 0.86 ( 94) -0.04 (94) 0.48 (89) -0.20 (87) 
2 0.94 (100) 0.85 ( 92) -0.24 (92) 0.53 (83) -0.19 (77) 
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0.89 ( 98) 
-0.21 ( 97) -0.66 
0.01 (100) -0.54 
- O . l O (  98) -0.51 
0.43 ( 95) 0.33 
95) -0.27 (95) 0.30 (78) 
-0.52 (94) 0.30 (88) 
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98) 0.19 (88) 
100) 0.18 (83) 
98) 0.21 (78) 








-0.56 (87) . ,  
2 0.48 ( 79) 0.50 ( 79) 0.26 ( 79) 0.24 (79) -0.60 (77) 
3 0.49 ( 84) 0.49 ( 84) 0.32 ( 83) 0.19 (83) -0.55 (70) 
1 -0.5 ( 94) -0.07 ( 94) 0.04 ( 94) -0.23 (94) -0.51 (96) 
2 -0.10 ( 78) -0.09 ( 78) 0.10 ( 78) -0.29 (78) -0.45 (78) 
3 -0.20 ( 72) -0.19 ( 72) 0.03 ( 71) -0.41 (71) -0.41 (71) 
HB HCT RBC MCV %HBF %HBA, 
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In a previous report [Odenheimer et al, 19831, we used cluster analysis tech- 
niques and the hematological data collected at initial assessment to identify four 
hematologically distinct subgroups of patients. The mean values of the hematological 
data within these subgroups are presented in Table V. In all instances, the differences 
in mean values among groups are highly significant (P <O.OOOl). 
To assess whether individuals tend to maintain their relative rank in the sample 
with respect to these four subgroups, we calculated discriminant scores for each 
individual at each of the three follow-up intervals using the cluster assignment at 
initial assessment as the stratum for the analysis. In each follow-up interval, an 
individual was assigned to the group for which the probability of assignment was the 
greatest. The comparison of the classification at follow-up with the classification 
established at initial assessment is given in Table VI. Of the individuals with complete 
data at all three intervals, 46% of the males and 49% of the females were assigned to 
the same group at each of the follow-up periods as they had been assigned to at initial 
assessment, while 81% of the males and 83% of the females were assigned to the 
same group in at least two of the three intervals. Previously [Odenheimer et al, 19831 
we showed that individuals in subgroups 1 and 2 had relatively mild disease severity, 
whereas individuals in subgroups 3 and 4 had relatively severe manifestations of the 
disease. When hypothesizing that subgroups 1 and 2 represent one severity class and 
that subgroups 3 and 4 represent a second severity class, 86% of the males and 76% 
TABLE V. Distribution of Hematological Variables in the Four Subgroups Identified at Initial Assessment 
Subgroup N HB HCT RBC %HBF MCV %HBA2 
Males 
1 16 Mean 1 7.32 21.33 2.30 9.84 92.54 2.46 
2 36 M e a n 2  8.46 25.03 3.01 9.18 83.26 2.77 
3 20 Mean 3 9.43 27.47 3.09 16.53 88.86 2.30 
4 7 Mean4 9.70 29.01 4.13 14.91 71.21 2.42 
Overall mean 8.59 24.2.5 2.99 11.68 85.49 2.56 
Significance level 0.0000 0.0000 0.0000 0.0000 0.0000 0.0008 
Intraclass correlation 0.60 0.56 0.80 0.52 0.57 0.23 
Females 
1 21 Mean 1 7.73 22.6.5 2.58 7.86 88.00 2.82 
2 15 Mean2 8.48 24.97 3.29 10.24 76.25 2.84 
3 31 M e a n 3  8.76 25.88 2.89 14.17 90.13 2.33 
4 7 Mean4 10.02 30.40 3.62 15.7.5 84.55 2.33 
Overall mean 8.53 25.20 2.95 11.73 86.19 2.57 
Intraclass correlation 0.61 0.63 0.67 0.53 0.58 0.42 
Significance level 0.0Ooo 0.0000 0.0000 o.Ooo0 0.0000 0.0000 
TABLE V1. Cluster Assignments Based on Discriminant Functions on Follow-up 
No. intervals where 
assignment was the same as 
initial assessment 
~ ~ _ _ _ ~  Four clustcrs Two clusters" 
Males Females Males Fcniales 
Mcasurcments in all three intervals 3 o f 3  17 20 32 31 
2 o f 3  13 14 4 4 
I o f 3  5 5 1 5 
O o f 3  2 2 0 I 
Measurements in two intervals of 
threc 2 o f 2  19 16 27 22 
I of2 10 4 4 2 
0 o f 2  2 7 0 3 
"Clusters I and 2 combined. and clusters 3 and 4 combined. 
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of the females measured in all three intervals were classified into the same class at 
each interval as they had been assigned to at initial assessment, while 97% of the 
males and 85% of the females were classified into the same class in at least 2 of 3 
intervals. 
Since the maximum probability of assignment could be rather low (any proba- 
bility greater than 50% could be the maximum when the strata were defined by the 
two severity classes), we also evaluated the distribution of these assignment probabil- 
ities. Of the individuals assigned to the same severity class on follow-up as initial 
assessment, the median probability of assignment was 95% in males and 87% in 
females. 
DISCUSSION 
A number of investigators have asked whether a patient’s hematological status 
is associated with his or her clinical manifestations of the disease [Odenheimer et al, 
1983; Serjeant and Ashcroft, 1972; Serjeant, 1975; Stevens et al, 1981; Steinberg et 
al, 1973; Powars et al, 1980; Harkness, 19801. However, there have been no studies 
of the stability of the hemotological data over time. Longitudinal studies are a 
prerequisite for gaining a clear understanding of the role of these data in explaining 
the natural history of the clinical and hematological course of the disease. We have 
shown that the hematological variables are stable over time. The correlations of the 
hematological variables between intervals range from a low of 0.46 for %HBA2 in 
males to a high of 0.91 for %HbF in females (P <0.0001 for all correlations). The 
correlations that span two intervals (an average of 32 months) are of the same 
magnitude as those that span only one interval (an average of 16 months), suggesting 
that there is no decrease in the degree of stability of these variables as the time 
between measurements increases. Additionally, the stability of the bivariate correla- 
tions and the stability of the coefficients of the principal components over time 
suggests that the relationships among variables are stable. 
Of the six hematological variables considered in this paper, %HbF has been 
most often hypothesized as being associated with variation in the clinical severity of 
sickle cell anemia [Serjeant and Ashcroft, 1972; Stevens et al, 1981; Steinberg et al, 
1983; Powars et al, 1980; Ali, 1970; Perrine et al, 1972; Haghshenass et al, 19771. In 
our previous study examining the role of the hematological data in predicting disease 
severity, we found that %HbF (and its inverse relationship to %HBAZ) was most 
highly associated with disease severity in this sample of children. 
It is well documented that %HbF levels drop with increasing age, at least up 
until age 35 [Rucknagel et al, 19791. In our sample, age accounted for approximately 
25% of the variability in %HbF. Age-adjusted %HbF levels were very highly 
correlated over time, ranging from 0.82 to 0.91. Thus, although the %HbF level of 
an individual younger than 20 years is likely to drop with time, his or her relative 
rank in the sample is very stable. The relationship between %HbF and disease severity 
reported previously, and its high stability reported here, suggests that a single %HbF 
measurement may be useful in predicting the clinical course of patients with sickle 
cell anemia. Since most of the hematologic measurements used were gathered in an 
outpatient setting, this analysis does not preclude short-term changes, such as may 
occur when patients enter crises. 
The relatively low stability of the proportion of HBAz is a curious observation, 
given the inverse correlation between the proportion of HbF and HBA2. It is difficult 
to attribute it to technical factors since elution of the hemoglobin components from 
cellulose acetate strips is regarded as an accurate and reproducible method of analysis. 
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A more likely explanation is the well-known relationship between serum iron concen- 
tration and HBA2. Iron deficiency, prevalent in growing children, would lower 
proportion of HBA2. However, a corresponding positive correlation between MCV 
and HBAz is not present. Therefore other environmental factors, such as folate 
deficiency, may be involved. 
The identification of heterogeneous subgroups of patients is an important first 
step in identifying groups of individuals that can be compared for genetic and 
environmental factors that contribute to the clinical heterogeneity of sickle cell 
anemia. Our finding that the subgroups identified at initial assessment are generally 
stable over time demonstrates that the factors that contributed to this classification are 
the result of stable, rather than transient phenomena. Although these factors are still 
unknown, the identification of stable hematological phenotypes based on a multivar- 
iate profile of hematological data provides a powerful framework for conducting the 
studies that will establish the links between genetic and environmental factors and 
disease heterogeneity. 
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